ストックスクリーナーアプリを入手
12.41
3.68%
0.44
アフターアワーズ：
12.41
Embecta Corp (EMBC) 最新ニュース
Positive Outlook for Embecta Corporation Amid Strong Financial Performance and Strategic Initiatives - TipRanks
Cautious Optimism for Embecta Corporation Amid Challenging Environment and Hold Rating - TipRanks
Embecta Corp. (NASDAQ:EMBC) Q2 2025 Earnings Call Transcript - Insider Monkey
Embecta Q2 2025 slides: Revenue decline offset by margin improvement and debt reduction - Investing.com
Earnings call transcript: Embecta Q2 2025 beats EPS forecast, stock dips - Investing.com Nigeria
Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline By GuruFocus - Investing.com Canada
Embecta Corporation Reports Q2 2025 Financial Results - TipRanks
Embecta earnings beat by $0.17, revenue topped estimates - Investing.com Nigeria
Embecta Corp’s Earnings Call: Progress Amid Challenges - TipRanks
Embecta to undergo further restructuring, lowers guidance amid tariff impact - MassDevice
Embecta reports Q2 adjusted EPS 70c, consensus 59c - TipRanks
Embecta Q2 2025 Earnings Call Transcript - MarketBeat
Transcript : Embecta Corp., Q2 2025 Earnings Call, May 09, 2025 - marketscreener.com
Why Is Embecta Stock Falling On Friday? - Yahoo Finance
EMBC Reports Q2 Revenue Slightly Below Expectations, Adjusts Gui - GuruFocus
Embecta Keeps Quarterly Dividend at $0.15 a Share; Payable June 13 to Holders of Record as of May 28 - marketscreener.com
embecta Announces Quarterly Cash Dividend - GlobeNewswire
Embecta Corp. (EMBC) Tops Q2 Earnings Estimates - Yahoo Finance
Embecta beats Q2 expectations, maintains full-year EPS outlook By Investing.com - Investing.com Nigeria
Embecta beats Q2 expectations, maintains full-year EPS outlook - Investing.com Australia
What Is Embecta Corp.'s (NASDAQ:EMBC) Share Price Doing? - simplywall.st
EMBC Reports Q2 Revenue Slightly Below Expectations, Adjusts Guidance | EMBC Stock News - GuruFocus
Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results - Stock Titan
Embecta Corp. Q2 Profit Decreases, But Beats Estimates - Nasdaq
Earnings Flash (EMBC) EMBECTA CORP. Posts Q2 Revenue $259M, vs. FactSet Est of $253.9M - marketscreener.com
Embecta Corp. Updates Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
Is Now An Opportune Moment To Examine Embecta Corp. (NASDAQ:EMBC)? - Yahoo Finance
Embecta Announces Quarterly Cash Dividend - marketscreener.com
EMBECTA Earnings Preview: Recent $EMBC Insider Trading, Hedge Fund Activity, and More - Nasdaq
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail
Embecta To Participate At The J.P. Morgan Global Leveraged Finance Conference - Barchart.com
Embecta Corp. to Host Analyst and Investor Day on May 22, 2025 in New York City - Nasdaq
Embecta to host Analyst and Investor Day on May 22, 2025 - Bluefield Daily Telegraph
Embecta Leaders to Reveal Long-term Growth Strategy and Financial Targets at Exclusive Investor Day - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
embecta to Report Fiscal Second Quarter 2025 Financial Results - The Manila Times
Embecta Corp. to Host Conference Call for Fiscal Q2 2025 Financial Results on May 9, 2025 - Nasdaq
Embecta Corp (EMBC) Stock Price Down 4.37% on Apr 14 - GuruFocus
Mizuho Initiates Coverage of Embecta (EMBC) with Neutral Recommendation - Nasdaq
Mizuho Initiates Embecta at Neutral With $15 Price Target - marketscreener.com
Mizuho sets Embecta stock with Neutral rating, $15 price target By Investing.com - Investing.com Canada
Mizuho sets Embecta stock with Neutral rating, $15 price target - Investing.com
Embecta Corporation: Hold Rating Amid Market Shifts and Strategic Uncertainties - TipRanks
(EMBC) Trading Advice - news.stocktradersdaily.com
Embecta shares study highlighting need for training, standardization in insulin delivery - Drug Delivery Business
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations - GlobeNewswire
Embecta Flat on Publication of Diabetes Education Piece - Baystreet.ca
Major Breakthrough: First Global Insulin Injection Guidelines in 10 Years Released by International Experts - Stock Titan
Embecta announces new publication in Mayo Clinic Proceedings on FITTER - TipRanks
6.51%
大文字化:
|
ボリューム (24 時間):